Recombinant Human ARPP19 Protein，His

ARPP19 (cAMP-regulated phosphoprotein 19) is a protein that plays a crucial role in the regulation of neuronal signaling pathways, particularly those mediated by cyclic AMP (cAMP) and protein kinase A (PKA). Its significance lies in its involvement in various neurobiology processes, including synaptic plasticity and learning and memory functions. Research on ARPP19 has gained momentum due to its implication in neuropsychiatric disorders, such as schizophrenia and depression, where dysregulation of cAMP signaling is often observed. The study of recombinant ARPP19 protein allows for a detailed understanding of its structure, function, and interactions with other signaling molecules, which is essential for elucidating its role in cellular processes. Recombinant technology facilitates the production of ARPP19 in a controlled manner, enabling researchers to investigate its biochemical properties, phosphorylation states, and conformational changes in response to cAMP levels. Such studies are vital for identifying potential therapeutic targets and drug development strategies aimed at restoring normal signaling pathways in affected populations. Additionally, exploring the role of ARPP19 in various cellular contexts may provide insights into the broader mechanisms of neurosignaling and its impact on behavior and cognition. Overall, the investigation of ARPP19 as a recombinant protein stands at the intersection of molecular biology, pharmacology, and neuroscience, offering promising avenues for advancing our understanding of both fundamental biology and clinical implications in mental health.